PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Steven Kesten Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

10/2008	A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
08/2008	Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary disease.
04/2008	Comparison of tiotropium bromide and combined ipratropium/salbutamol for the treatment of COPD: a UK General Practice Research Database 12-month follow-up study.
01/2008	Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients.
01/2007	Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.
09/2006	Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
12/2005	Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease.
09/2005	Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.
09/2005	Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.
03/2005	Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
01/2004	Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial.
01/2004	Eletrocardiographic monitoring in COPD patients receiving tiotropium.
01/2004	Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
11/2003	Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
05/2003	Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
07/2002	A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

Articles by Research Topic

Disease

16	Chronic Obstructive Pulmonary Disease (COPD) 10/2008 - 07/2002

Drug/Important Bio-Agent (IBA)

16	tiotropium (Spiriva)FDA Link 10/2008 - 07/2002
2	salmeterol (Serevent)FDA Link 01/2007 - 07/2002
1	Albuterol (Salbutamol)FDA LinkGeneric 04/2008
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 04/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2007